Reports
Efficacy Testing Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030
REPORT DETAILS
REPORT DETAILS
ABOUT THIS REPORT
The global efficacy testing market was valued at USD 298.01 million in 2021 and is expected to grow at a CAGR of 6.2% during the forecast period. The industry is primarily driven by the expanding pharmaceutical and biotechnology industries, which are supported by government policies and are witnessing a positive trend in their research and development activities.
Know more about this report: Download Sample Report
Efficacy testing is used to establish the proficiency of the product by analyzing the toxicology test, stability test, and protection test. Clinical trials, in particular efficacy studies, provide objective verification of a product's effectiveness using specialized equipment and scientific methods.
Since the major objective of this kind of study is to ascertain how well a sponsor-developed product such as cream performs for a certain claim, the demand for the industry is expected to grow. The clinical study development evaluates the effectiveness of a product by assessing many predefined criteria and utilizing scientific methodologies in order to acquire improved quantitative results.
The outbreak of the Covid-19 pandemic had a positive impact on the efficacy testing market. The COVID-19 pandemic changed how people view cleanliness, causing an anxious demand for disinfection products that quickly depleted their stock, which in turn, accelerated the growth of the industry.
Furthermore, governmental organizations also announced special financial aid for the development of preventive and curative drugs, the purchase of critical care medical devices, and the fast-track approval of diagnostic tests in response to the EPA adding numerous natural disinfectants to its "approved" list for combating COVID-19.
Know more about this report: Download Sample Report
Industry Dynamics
Growth Drivers
The primary factors fueling the growth of the efficacy testing market are the rise in consumer health concerns, changes in lifestyle, an increase in cosmetic products by the Gen-Z population, and increased consumer awareness of the advantages and necessity of products that have undergone certification examination.
There are several opportunities in the efficacy testing market as a result of the research and development activities of several businesses and government organizations that have grown quickly. Due to the industry’s enormous development potential and underutilized customer base, emerging economies have drawn significant investments from all over the world. The industry is expected to grow as a result of these factors.
Report Segmentation
The market is primarily segmented based on service type, application, and region.
| By Service Type | By Application | By Region |
|
|
|
Know more about this report: Download Sample Report
Disinfectant efficacy testing segment accounted for the largest share
The growth of the market in the disinfectant efficacy testing segment is attributed to the increasing production and use of surface disinfectants owing to rising awareness of personal hygiene among consumers.
Furthermore, the rising environmental concern among people is another factor contributing to the growth of the industry. The growing need to determine the biocidal effect of a disinfectant in the environment as well as validate sanitizing agents for effectiveness against organisms is projected to fuel the demand for the industry.
Pharmaceutical manufacturing applications segment accounted for the largest share
The demand for the market in the pharmaceutical sector is driven by the R&D investments in the life sciences sector as well as the expanding use of antimicrobial efficacy testing for various types of medical devices in the pharmaceutical and cosmetic industries.
Furthermore, the strict restrictions on the microbiological testing of pharmaceutical medications for regulatory approval and the increasing emphasis on patient safety are largely responsible for the growth of this market.
North America accounted for the largest share in the global market in 2021
North America dominated with the largest revenue share in 2021. The demand for the market was further increased by high pharmaceutical company investment in R&D in this region, stringent drug development laws, and rising government expenditure for life science research activities.
Moreover, Asia Pacific is expected to witness a high CAGR in the global efficacy testing market in 2021. The main factors driving the growth of efficacy testing in the Asia Pacific are the aging population, the rapid rise in chronic diseases, and rising investments in better healthcare facilities. The public's rising health consciousness has also increased the demand for these services and goods.
Competitive Insight
Some of the major players operating in the global market include:
- Abbott Analytical,
- Accugen Laboratories, Inc.,
- Almac Group,
- ALS Limited,
- Bioscience Laboratories, Inc.,
- Blutest Laboratories Limited,
- Charles River Laboratories International, Inc.,
- Consumer Product Testing Company (CPTC),
- Eurofins Scientific,
- Helvic Laboratories (A Tentamus Company),
- Intertek Group PLC,
- Lucideon, Microchem Laboratory,
- MSL Solution Providers,
- Nelson Laboratories,
- LLC (A Sotera Health Company),
- North American Science Associates,
- Pacific Biolabs,
- SGS SA,
- Toxikon,
- Wuxi Apptec.
Recent Developments
July 2023: SGS expanded its Shanghai lab in China, boosting capacity to test cosmetics and personal care products due to Asia-Pacific market growth.
June 2022: Eurofins Cosmetics & Personal Care acquired a majority stake in CRA Korea Inc., a South Korea lab offering safety and efficacy studies, consumer tests, and sensory evaluations for cosmetics and personal care.
May 2022: The Pfizer-BioNTech COVID-19 vaccine showed strong immune response, high efficacy, and good safety in children 6 months to under 5 years after the third dose. Vaccine efficacy was 80.3% when Omicron was dominant.
Efficacy Testing Market Report Scope
| Report Attributes | Details |
| Market size value in 2021 | USD 298.01 million |
| Revenue forecast in 2030 | USD 511.64 million |
| CAGR | 6.2% from 2022 - 2030 |
| Base year | 2021 |
| Historical data | 2018 - 2020 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2030 |
| Segments covered | By Service Type, By Application, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Key companies | Abbott Analytical, Accugen Laboratories, Inc., Almac Group, ALS Limited, Bioscience Laboratories, Inc., Blutest Laboratories Limited, Charles River Laboratories International, Inc., Consumer Product Testing Company (CPTC), Eurofins Scientific, Helvic Laboratories (A Tentamus Company), Intertek Group PLC, Lucideon, Microchem Laboratory, MSL Solution Providers, Nelson Laboratories, LLC (A Sotera Health Company), North American Science Associates, Pacific Biolabs, SGS SA, Toxikon, and Wuxi Apptec |
FAQ's
The global efficacy testing market was valued at USD?298.01?million in 2021 and is expected to grow at a CAGR of 6.2% to reach USD?511.64?million by 2030.
Market expansion is driven by the increasing pharmaceutical and biotechnology R&D activities, government support for life science research, growing awareness of product safety and hygiene, and rising demand for scientific validation of product effectiveness.
The market includes key service types such as antimicrobial/preservative efficacy testing and disinfectant efficacy testing, with disinfectant testing currently holding the largest share due to heightened personal hygiene awareness globally.
Applications span pharmaceutical manufacturing, cosmetics and personal care products, consumer product testing, and medical device testing, reflecting broad industry reliance on efficacy validation across product types.
North America accounted for the largest share of the efficacy testing market in 2021, supported by high pharmaceutical R&D investment, stringent regulatory requirements, and significant government expenditure on life science research.
Asia Pacific is anticipated to witness strong growth due to increasing healthcare investments, aging populations, rising prevalence of chronic diseases, and growing consumer demand for quality assured products.
Major companies operating in the efficacy testing market include Abbott Analytical, Accugen Laboratories, Almac Group, ALS Limited, Bioscience Laboratories, Charles River Laboratories, Eurofins Scientific, Intertek Group, Microchem Laboratory, Nelson Laboratories, Pacific Biolabs, SGS SA, Toxikon, and Wuxi Apptec.
Download Sample Report of Efficacy Testing Market
Please fill out the form to request a customized copy of the research report.
